Glutamate AMPA receptor subunit 1 gene (GRIA1) and DSM-IV-TR schizophrenia : a pilot case-control association study in an Italian sample
Copyright 2006 Wiley-Liss, Inc..
Glutamatergic dysfunction is one of the major hypotheses for the pathogenesis of schizophrenia. The GRIA1 gene encodes for one (GluR1) of the four (GluR1-4) ionotropic AMPA receptor subunits. GRIA1 is a good candidate gene for susceptibility to schizophrenia since it maps in 5q33, a region where the presence of susceptibility loci has been suggested by independent genome-wide scans and because its expression has been found to be decreased in the brain of some schizophrenia patients. We present data from a case-control association study on the Italian population with eight polymorphisms spanning the whole GRIA1 gene. Single-locus analysis revealed a significantly different allele distribution in cases and in controls of two SNPs (rs707176, 0.41 vs. 0.31, P = 0.009; rs2963944, 0.41 vs. 0.30, P = 0.007), and one microsatellite (rs10631988, allele 9: 0.40 vs. 0.29, P = 0.004). Haplotype analysis showed an increased frequency of a specific haplotype for these markers (C09CC, 0.39 vs. 0.28, P = 0.009). Therefore our data indicate that GRIA1 may be involved in susceptibility to DSM-IV-TR schizophrenia.
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2006 |
---|---|
Erschienen: |
2006 |
Enthalten in: |
Zur Gesamtaufnahme - volume:141B |
---|---|
Enthalten in: |
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics - 141B(2006), 3 vom: 05. Apr., Seite 287-93 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Magri, Chiara [VerfasserIn] |
---|
Themen: |
Glutamate receptor ionotropic, AMPA 1 |
---|
Anmerkungen: |
Date Completed 30.05.2006 Date Revised 30.09.2020 published: Print Citation Status MEDLINE |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
NLM161168159 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM161168159 | ||
003 | DE-627 | ||
005 | 20231223091626.0 | ||
007 | tu | ||
008 | 231223s2006 xx ||||| 00| ||eng c | ||
028 | 5 | 2 | |a pubmed24n0537.xml |
035 | |a (DE-627)NLM161168159 | ||
035 | |a (NLM)16526023 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Magri, Chiara |e verfasserin |4 aut | |
245 | 1 | 0 | |a Glutamate AMPA receptor subunit 1 gene (GRIA1) and DSM-IV-TR schizophrenia |b a pilot case-control association study in an Italian sample |
264 | 1 | |c 2006 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
500 | |a Date Completed 30.05.2006 | ||
500 | |a Date Revised 30.09.2020 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright 2006 Wiley-Liss, Inc. | ||
520 | |a Glutamatergic dysfunction is one of the major hypotheses for the pathogenesis of schizophrenia. The GRIA1 gene encodes for one (GluR1) of the four (GluR1-4) ionotropic AMPA receptor subunits. GRIA1 is a good candidate gene for susceptibility to schizophrenia since it maps in 5q33, a region where the presence of susceptibility loci has been suggested by independent genome-wide scans and because its expression has been found to be decreased in the brain of some schizophrenia patients. We present data from a case-control association study on the Italian population with eight polymorphisms spanning the whole GRIA1 gene. Single-locus analysis revealed a significantly different allele distribution in cases and in controls of two SNPs (rs707176, 0.41 vs. 0.31, P = 0.009; rs2963944, 0.41 vs. 0.30, P = 0.007), and one microsatellite (rs10631988, allele 9: 0.40 vs. 0.29, P = 0.004). Haplotype analysis showed an increased frequency of a specific haplotype for these markers (C09CC, 0.39 vs. 0.28, P = 0.009). Therefore our data indicate that GRIA1 may be involved in susceptibility to DSM-IV-TR schizophrenia | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 7 | |a Receptors, AMPA |2 NLM | |
650 | 7 | |a glutamate receptor ionotropic, AMPA 1 |2 NLM | |
650 | 7 | |a TFZ3H25BS1 |2 NLM | |
700 | 1 | |a Gardella, Rita |e verfasserin |4 aut | |
700 | 1 | |a Barlati, Stefano Davide |e verfasserin |4 aut | |
700 | 1 | |a Podavini, Damiano |e verfasserin |4 aut | |
700 | 1 | |a Iatropoulos, Paraskevas |e verfasserin |4 aut | |
700 | 1 | |a Bonomi, Silvia |e verfasserin |4 aut | |
700 | 1 | |a Valsecchi, Paolo |e verfasserin |4 aut | |
700 | 1 | |a Sacchetti, Emilio |e verfasserin |4 aut | |
700 | 1 | |a Barlati, Sergio |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics |d 2003 |g 141B(2006), 3 vom: 05. Apr., Seite 287-93 |w (DE-627)NLM122808355 |x 1552-485X |7 nnns |
773 | 1 | 8 | |g volume:141B |g year:2006 |g number:3 |g day:05 |g month:04 |g pages:287-93 |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 141B |j 2006 |e 3 |b 05 |c 04 |h 287-93 |